コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 bacteria is both a virulence factor and a B-cell antigen.
2 g (Jedi) T cells enable visualization of a T-cell antigen.
3 esponse to HtrABb, indicating that it is a B-cell antigen.
4 installation of a TLR2/6 agonist and a MAIT cell antigen.
5 eby activating immune responses against dead-cell antigens.
6 lenging to identify relevant peptide-based T cell antigens.
7 , Th1 reactivity spread from EGFP to other B-cell antigens.
8 nses to EGFP which did not spread to other B-cell antigens.
9 rable splenocyte and serum reactivity to B16 cell antigens.
10 ze endothelial, gastrointestinal, and immune-cell antigens.
11 litis), and autoantibodies specific for beta-cell antigens.
12 omparative gene expression profiling of stem cell antigen 1(-) (Sca1(-)) and Sca1(+) neonatal fibrobl
13 ngII signature proteins (bone marrow stromal cell antigen 1, glutamine synthetase [GLNA], laminin sub
16 mol/umol of creatinine], bone marrow stromal cell antigen 1: 3.8 versus 3.0, P = 0.03; GLNA: 1.2 vers
17 the role of Toll-like receptor 4 (TLR4)/stem cell antigen-1 (Sca-1) signaling in this process, bacter
18 s in adult mouse myocardium all sharing stem cell antigen-1 (Sca1), based on side population (SP) phe
19 be documented by the down-regulation of stem cell antigen-1 and acquisition of responsiveness to gran
20 ny-forming unit progenitors coexpressed stem cell antigen-1 and CD45 and were adventitially located,
21 distinct from neighboring cells lacking stem cell antigen-1 or CD45 and contained a proliferative (Ki
22 ariable models revealed more blood dendritic cell antigen-1(+) (BDCA-1(+)) myeloid dendritic cells (m
24 ontained abundant stem cells expressing stem cell antigen-1, Wilms' tumor 1 (WT-1), and CD34, suggest
27 (SPC)(+) alveolar type 2 cells and in Clara cell antigen 10 (CC10)(+) Clara cells by use of cell-typ
32 IFN-I-regulated ligand, bone marrow stromal cell antigen 2 (BST2) plays a key role in controlling th
34 0-amino-acid autotransporter protein surface cell antigen 2 (Sca2) promotes actin polymerization on t
36 ficant downregulation of bone marrow stromal cell antigen-2 (BST2), a potential therapeutic target, v
37 ransposon mutagenesis, we identified surface cell antigen 4 (Sca4) as a secreted effector of spread t
38 n (Ig) molecules that efficiently capture ss-cell antigens allows autoreactive B-lymphocytes bypassin
39 of the NAb targets gD and gB and the novel T cell antigen and tegument protein UL40, and we compared
40 f inflammatory T-cell responses to apoptotic cell antigens and failure of long-tolerance induction.
43 eated a novel category of tumor-associated T-cell antigens based on their exclusive and frequent repr
44 meric antigen receptor (CAR) targeting the B cell antigen CD19 have yielded remarkable clinical respo
46 hus, the spreading of autoreactivity among B-cell antigens corresponded with the transition from peri
47 tion of proteins mucin-5AC and prostate stem-cell antigen could identify high-grade dysplasia/cancer
48 unctions empowered by specific delivery of T cell antigens could be harnessed for tolerance induction
50 we describe the first report of a human mast cell antigen-dependent passive systemic anaphylaxis resp
54 d that pDCs accumulated at sites of CD8(+) T cell antigen-driven activation in a CCR5-dependent fashi
55 n epitope that is an immunodominant CD8(+) T cell antigen during primary infection of C57BL/6 mice wi
57 face receptors (CD19-22) to immunodominant T-cell antigens from EBV proteins, including EBNA1, EBNA3B
59 ient to initiate expression of smooth muscle cell antigens in ASC, only activin A IgG blocked the eff
60 physics, and functional assays to identify T-cell antigens in long-term survivors of pancreatic cance
63 identified to be a dominant murine CD4(+) T cell antigen, its level of expression during the bacteri
67 g the expression of the neuroectodermal stem cell antigen, nestin, and up-regulating the glial matura
70 ns from 1:100 to 1:102,400 using crude whole-cell antigens of the Karp, Kato, and Gilliam strains of
71 entation of established myeloma-associated T-cell antigens on the HLA ligandome level, we found a sub
72 ET data of mice implanted with prostate stem cell antigen-overexpressing tumors and injected with (12
74 emerged as a critical regulator of dendritic cell antigen presentation, but its role in T-cell immuni
75 echanism of protection may involve lack of B cell antigen presentation, which impairs T-cell activati
80 en shown to induce activation of endothelial cells, antigen-presenting cells, and platelets, resultin
82 -terminal cysteine of the anti-prostate stem cell antigen (PSCA) cys-diabody A2, and subsequently rad
87 RK activity and CLL proliferation required B cell antigen receptor (BCR) activation, as inhibition of
89 respond to antigens by engagement of their B-cell antigen receptor (BCR) and of coreceptors through w
90 es encoding the variable (V) region of the B-cell antigen receptor (BCR) are assembled from V, D (div
91 obial molecules, enhance signalling by the B-cell antigen receptor (BCR) by activating the actin-seve
92 Mature B cells coexpress both IgM and IgD B-cell antigen receptor (BCR) classes, which are organized
93 ry on their surface multiple copies of the B cell antigen receptor (BCR) comprising the membrane-boun
94 milar to resting mature B cells, where the B-cell antigen receptor (BCR) controls cellular survival,
98 cytosolic Ca(2+) following ligation of the B cell antigen receptor (BCR) led to the assumption that t
103 kinase (Erk) activation mediated by tonic B-cell antigen receptor (BCR) signaling and that this sign
105 ism of Lin28b action nor the importance of B cell antigen receptor (BCR) signaling in this process wa
107 In B-lymphocytes, the down-regulation of B-cell antigen receptor (BCR) signaling is critical for su
108 egulating tonic, but not antigen-mediated, B-cell antigen receptor (BCR) signaling through modulation
109 are selected for an intermediate level of B-cell antigen receptor (BCR) signalling strength: attenua
114 such as the T cell antigen receptor (TCR), B cell antigen receptor (BCR), and Fc receptors uses the s
115 kinase is essential for signaling from the B cell antigen receptor (BCR), and thus for antibody respo
117 ell development requires expression of the B cell antigen receptor (BCR), it remains unclear whether
118 into cytoplasmic signaling events through B-cell antigen receptor (BCR)-based signalosomes at the B-
120 on compromises the activity of the pivotal B-cell antigen receptor (BCR)-proximal effector spleen tyr
123 In B lymphopoiesis, activation of the pre-B cell antigen receptor (pre-BCR) is associated with both
124 gnaling components of the precursor to the B cell antigen receptor (pre-BCR), including defects in BL
127 ) following suboptimal stimulation via the T cell antigen receptor (TCR) (induced T(reg) cells (iT(re
129 tions further differed in their use of the T cell antigen receptor (TCR) alpha-chain variable region
131 rom naive precursors when signals from the T cell antigen receptor (TCR) and certain cytokine recepto
132 acted in synergy with stimulation via the T cell antigen receptor (TCR) and coreceptor CD28 to accel
133 T cells lost the signaling activity of the T cell antigen receptor (TCR) and expressed a protein comp
134 olecules associated with activation of the T cell antigen receptor (TCR) and of immunological-checkpo
135 The expression of Myc is regulated by the T cell antigen receptor (TCR) and pro-inflammatory cytokin
136 d directly with the signal strength of the T cell antigen receptor (TCR) and required the coreceptor
137 ganization of CD4, and its relationship to T-cell antigen receptor (TCR) and the active form of Src k
138 h ITAM multiplicity) in the complex of the T cell antigen receptor (TCR) and the invariant signaling
139 We found that clonotypes expressing the T cell antigen receptor (TCR) beta-chain variable region 1
140 osphatase PTPN22 limited signaling via the T cell antigen receptor (TCR) by weak agonists and self an
141 Variable strengths of signaling via the T cell antigen receptor (TCR) can produce divergent outcom
144 mplex (MHC) proteins are recognized by the T cell antigen receptor (TCR) dictates the homeostasis of
148 ypes generally show simplified patterns of T cell antigen receptor (TCR) expression, rapid effector r
150 was strongly induced by activation of the T cell antigen receptor (TCR) in a pathway involving calci
151 nterleukin 17 (IL-17), but the role of the T cell antigen receptor (TCR) in this developmental proces
154 Although heightened signaling via the T cell antigen receptor (TCR) is critical for the differen
158 The kinetic proofreading model can explain T cell antigen receptor (TCR) ligand discrimination; howev
159 requires interleukin 2 (IL-2) and agonist T cell antigen receptor (TCR) ligands and is controlled by
164 RNA-seq for assessing T-cell clonality and T-cell antigen receptor (TCR) repertoire of the neoplastic
166 le-cell RNA sequencing and high-throughput T cell antigen receptor (TCR) sequencing to characterize t
168 tors and cell-intrinsic factors related to T cell antigen receptor (TCR) signal quantity and quality.
169 ng the nature of molecules involved in the T cell antigen receptor (TCR) signal transduction network,
170 ound that calcineurin was recruited to the T cell antigen receptor (TCR) signaling complex, where it
172 CD8(+) T cells in the thymus requires that T cell antigen receptor (TCR) signaling end in time for cy
173 immunity and requires a limited degree of T cell antigen receptor (TCR) signaling in response to sel
177 catalytic activity of Zap70 is crucial for T cell antigen receptor (TCR) signaling, but the quantitat
178 nd WASP-interacting-protein (WIP) regulate T cell antigen receptor (TCR) signaling, but their role in
179 To investigate how Csk activity regulates T cell antigen receptor (TCR) signaling, we utilized a mou
184 sensor of thresholds for signaling via the T cell antigen receptor (TCR) that was essential for T cel
186 ever, the mechanisms that allow the clonal T cell antigen receptor (TCR) to functionally engage multi
187 A and Foxp1D induced by stimulation of the T cell antigen receptor (TCR) to inhibit the generation of
188 nd the tyrosine phosphatase CD45 underpins T cell antigen receptor (TCR) triggering, but how such seg
190 played enhanced proximal signaling via the T cell antigen receptor (TCR) without an effect on the act
191 ransduction by immunoreceptors such as the T cell antigen receptor (TCR), B cell antigen receptor (BC
192 ting THEMIS in signaling downstream of the T cell antigen receptor (TCR), but the mechanistic underpi
194 We demonstrate that upon ligation of the T-cell antigen receptor (TCR), the TCR associates with and
195 n T cells in response to engagement of the T cell antigen receptor (TCR), which induced expression of
200 anistically, we demonstrate a link between T cell antigen receptor (TCR)-induced asymmetric expressio
201 operated Ca(2+) channel and contributed to T cell antigen receptor (TCR)-induced Ca(2+) influx, TCR s
202 Analysis of 11 crystal structures of MAIT T cell antigen receptor (TCR)-MR1-AML ternary complexes, a
211 is a critical mediator of signaling by the T cell antigen receptor and the principal costimulatory re
214 s to tyrosine kinases and may regulate the T-cell antigen receptor biological activities for this cel
215 f immature B cells after engagement of the B cell antigen receptor by suppressing the expression of t
216 th human T-lymphotropic virus type 1; (ii) T cell antigen receptor clonotype repertoires; and (iii) m
218 findings indicate that the affinity of the T cell antigen receptor for self antigen drives the differ
220 n CD4(+) T cells, prior activation via the T cell antigen receptor limits IL-6's control of STAT1 in
223 han did Foxp3(lo) T(reg)P cells, and had a T cell antigen receptor repertoire and transcriptome disti
224 TEC) is essential for generating a diverse T cell antigen receptor repertoire tolerant to self-antige
229 mocyte positive selection by enhancing the T cell antigen receptor signaling response to low-affinity
232 tional role for mTORC1 was revealed when a B-cell antigen receptor transgene was found to circumvent
233 AT) is a critical signaling hub connecting T cell antigen receptor triggering to downstream T cell re
235 ors display altered alpha3135-145-specific T-cell antigen receptor usage, HLA-DR15-alpha3135-145 tetr
236 chanisms in vitro after activation via the T cell antigen receptor, resulting in antigen-independent
244 ting MR1-Ag complexes are recognized by MAIT cell antigen receptors (alphabeta T cell receptors (TCRs
245 s by selection of somatically hypermutated B cell antigen receptors (BCR) on immune complexes (ICs).
248 responses, T cells harboring high-affinity T cell antigen receptors (TCRs) are preferentially expande
250 d molecules are subsequently recognized by T cell antigen receptors (TCRs) expressed on the surface o
252 estion is whether an altered repertoire of T cell antigen receptors (TCRs) is associated with such ex
254 features, including variable sequences of T cell antigen receptors (TCRs) that confer antigen specif
257 spond rapidly to stress despite expressing T cell antigen receptors (TCRs), a hallmark of adaptive im
261 s is controlled by tonic signaling through T cell antigen receptors and common gamma chain cytokine r
262 lymphocyte-like cells that lack T cell or B cell antigen receptors and mediate protective and repair
263 g the balance of persistent stimulation of T-cell antigen receptors and specific CD2-induced co-stimu
264 or optimal cell surface expression of mIgE B-cell antigen receptors but not for intracellular IgE exp
265 ndividuals, indicating strong selection of B cell antigen receptors even in the absence of microbiota
268 olvent-exposed and therefore accessible to T-cell antigen receptors were predicted to be immunogenic.
269 heckpoint inhibition, mAbs, and engineered T-cell antigen receptors, the incidence and pattern of mal
270 and involving synergistic stimulation via B-cell antigen receptors, toll-like receptor 7 (TLR7), and
271 cells, enriched for self antigen-specific T cell antigen receptors, was also present in healthy host
275 of the most noted haptens, are gammadelta T cell antigens, recognized directly by specific gammadelt
278 n type 1 diabetes, loss of tolerance to beta-cell antigens results in T-cell-dependent autoimmune des
282 2B adenosine receptors on mouse cardiac stem cell antigen (Sca)-1(+)CD31(-) mesenchymal stem-like cel
283 jects reflects the complex requirements of B-cell antigen signaling, activation, survival, migration,
285 ntigen-specific effector CD8(+) and CD4(+) T cells, antigen-specific cytokine release, inhibition of
286 tion of antigen-specific follicular helper T cells, antigen-specific GC B cells, and high-affinity cl
287 e on development and function of human CD4 T cells, antigen-specific human CD8 T cells, and immunoglo
288 ) lymphocyte-activation gene 3 (LAG3)(+) TR1 cells, antigen-specific proliferative responses, and cyt
290 Herein, we discuss different forms of NK cell antigen specificity and how these responses may be
292 le in animal models of UL40, a novel HSV-2 T cell antigen that has been correlated with asymptomatic
293 Our data describe a novel aspect of memory T cell antigen threshold sensitivity that may critically r
298 cells (EBV(+) in >90% of cells) expressed B-cell antigens, were often CD30 and PD-L1 positive, and s
299 GD3 can serve as a natural killer T (NKT) cell antigen when presented on CD1d molecules expressed
300 an immunofluorescence assay utilizing whole cell antigens, which are both dangerous and laborious to